Pursuant to section 35(1)(a) of the Medicines Act 1981, the Minister of Health hereby revokes consent to the distribution in New Zealand of the following medicines:
Product: Meridia
Active Ingredient: Sibutramine hydrochloride monohydrate 10mg
Dosage Form: Capsule
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Product: Meridia
Active Ingredient: Sibutramine hydrochloride monohydrate 15mg
Dosage Form: Capsule
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Product: Reductil
Active Ingredient: Sibutramine hydrochloride monohydrate 10mg
Dosage Form: Powder filled capsule
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Product: Reductil
Active Ingredient: Sibutramine hydrochloride monohydrate 15mg
Dosage Form: Powder filled capsule
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Product: Reduxade
Active Ingredient: Sibutramine hydrochloride monohydrate 10mg
Dosage Form: Capsule
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Product: Reduxade
Active Ingredient: Sibutramine hydrochloride monohydrate 15mg
Dosage Form: Capsule
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Dated this 11th day of October 2010.
JANICE WILSON, Deputy Director-General, Population Health Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 20 December 2001 and the Director-General of Health on 18 January 2002).